<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310047</url>
  </required_header>
  <id_info>
    <org_study_id>Re_Injection</org_study_id>
    <nct_id>NCT03310047</nct_id>
  </id_info>
  <brief_title>Intra-individual Reproducibility in Nerve Block Duration</brief_title>
  <official_title>Intra-individual Reproducibility in Nerve Block Duration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nordsjaellands Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Innovation Fund Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nordsjaellands Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      An interventional randomized controlled crossover trial, to illuminate if durations in nerve
      block durations are predictable within the same subject.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An interventional randomized controlled crossover trial, with the purpose to elucidate the
      reproducibility in nerve block duration on 20 healthy volunteers in Denmark.

      There will be two trial arms:

      1: Day one; Right side low dose nerve block and left side high dose nerve block. Repeated
      after 24 hours. Day three; Left side low dose nerve block and right side high dose nerve
      block. Repeated after 24 hours

      2: Day one; Left side low dose nerve block and right side high dose nerve block Repeated
      after 24 hours Day three; Right side low dose nerve block and left side high dose nerve block
      Repeated after 24 hours

      All volunteers will receive two peripheral nerve blocking catheters adjacent to the common
      peroneal nerve and will be treated two times on each side with Lidocaine 0.5% 5 mL and 10 mL.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 30, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">March 1, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>We will use a two-armed crossover design.
Day one; Right side low dose nerve block and left side high dose nerve block
Repeated after 24 hours Day three; Left side low dose nerve block and right side high dose nerve block
Repeated after 24 hours
Day one; Left side low dose nerve block and right side high dose nerve block
Repeated after 24 hours Day three; Right side low dose nerve block and left side high dose nerve block
Repeated after 24 hours</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The process of intervention-implementation and intervention will not be in the participant's line of sight.
Investigators will not be in the room during the intervention. Outcome assessors will not be in the room during the intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of insensitivity towards cold</measure>
    <time_frame>Up to 10 hours</time_frame>
    <description>Time from nerve block onset time (T1) to nerve block remission (T2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset time</measure>
    <time_frame>Up to 30 minutes</time_frame>
    <description>Time from infusion (T0) to onset (T1) of the nerve blocking effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of sensory nerve block</measure>
    <time_frame>Up to 10 hours</time_frame>
    <description>A four step grading-scale of sensory nerve block intensity. 1 = normal, 2 = different, 3 = warm, 4 = no feeling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of motor nerve block</measure>
    <time_frame>Up to 10 hours</time_frame>
    <description>A three step grading-scale of motor nerve block intensity. 1 = normal, 2 = decreased strength, 3 = no strength.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Anesthesia, Regional</condition>
  <arm_group>
    <arm_group_label>Right-low, left-high</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The right-side perineural catheter will be subject to intervention drug Infusion, Lidocaine, 0.5%, 5 mL Lidocaine and the left side perineural catheter will be subject to intervention Infusion, Lidocaine, 0.5%, 10 mL.
This will be repeated after 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right-high, left-low</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The right-side perineural catheter will be subject to intervention drug Infusion, Lidocaine, 0.5%, 10 mL Lidocaine and the left side perineural catheter will be subject to intervention Infusion, Lidocaine, 0.5%, 5 mL.
This will be repeated after 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Infusion, Lidocaine, 0.5%, 5 mL</intervention_name>
    <description>A catheter-based perineural infusion of 5 mL Lidocaine 0.5%</description>
    <arm_group_label>Right-low, left-high</arm_group_label>
    <arm_group_label>Right-high, left-low</arm_group_label>
    <other_name>Low dose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Infusion, Lidocaine, 0.5%, 10 mL</intervention_name>
    <description>A catheter-based perineural infusion of 10 mL Lidocaine 0.5%</description>
    <arm_group_label>Right-low, left-high</arm_group_label>
    <arm_group_label>Right-high, left-low</arm_group_label>
    <other_name>High dose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years

          2. ASA classification ≤ II

        Exclusion Criteria:

          1. Allergy to local anaesthetics

          2. Body weight 40 kg

          3. Possible peripheral nerve injury or disease, including polyneuropathy and diabetes

          4. Enrolment or recent participation in studies that may interfere with this study

          5. Habitual use of any kind of analgesic medications

          6. Anatomic abnormalities preventing successful US-guided Certa Catheter™ insertion.

          7. Pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kai L Lange, MD, DMSci</last_name>
    <role>Study Director</role>
    <affiliation>Nordsjaellands Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Unit, Department of Anaesthesiology, Nordsjaellands Hospital Hilleroed</name>
      <address>
        <city>Hillerød</city>
        <state>Capital Region Of Denmark</state>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2017</study_first_submitted>
  <study_first_submitted_qc>October 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>May 13, 2018</last_update_submitted>
  <last_update_submitted_qc>May 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nordsjaellands Hospital</investigator_affiliation>
    <investigator_full_name>Mikkel Herold Madsen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

